These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6284361)

  • 1. Phase II trial of doxorubicin therapy for advanced islet cell carcinoma.
    Moertel CG; Lavin PT; Hahn RG
    Cancer Treat Rep; 1982 Jul; 66(7):1567-9. PubMed ID: 6284361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet cell carcinoma of the pancreas: effective therapy with 5-fluorouracil, streptozotocin, and tubercidin.
    Kraybill WG; Anderson DD; Lindell TD; Fletcher WS
    Am Surg; 1976 Jul; 42(7):467-70. PubMed ID: 180857
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II clinical evaluation of 4'-epi-doxorubicin.
    Hurteloup P; Cappelaere P; Armand JP; Mathé G
    Cancer Treat Rep; 1983 Apr; 67(4):337-41. PubMed ID: 6573956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Rose PG; Blessing JA; Lele S; Abulafia O
    Gynecol Oncol; 2006 Aug; 102(2):210-3. PubMed ID: 16478630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin analogues in the management of benign insulinomas.
    Laron Z
    Isr J Med Sci; 1990 Jan; 26(1):1-2. PubMed ID: 2155883
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.
    Lee J; Park JO; Kim WS; Park SH; Park KW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Joh J; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Park K
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):385-90. PubMed ID: 15248028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of insulinoma with the somatostatin analog SMS 201-995].
    Gilsanz Peral A; Gómez Balaguer M; Costa Talens P
    Med Clin (Barc); 1988 Apr; 90(15):634-5. PubMed ID: 2899658
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I clinical trial of topotecan and pegylated liposomal doxorubicin.
    Garcia AA; Roman L; Muderspach L; O'meara A; Facio G; Edwards S; Burnett A
    Cancer Invest; 2005; 23(8):665-70. PubMed ID: 16377584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin secreting islet cell carcinoma treated with streptozotocin (apropose of a case)].
    Chevrel JP; Amouroux J; Attali JR; Izou H
    Med Chir Dig; 1976; 5(1):25-31. PubMed ID: 189143
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of malignant metastatic pancreatic insulinoma with streptozotocin. Review of 21 cases described in detail in the literature and report of complete remission of a new case.
    Herbai G; Lundin A
    Acta Med Scand; 1976; 200(6):447-52. PubMed ID: 189576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
    Berman E; Casper ES; Howard J; Wittes RE
    Cancer Treat Rep; 1984 Apr; 68(4):679-80. PubMed ID: 6585272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
    Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
    Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant insulinoma: lack of response to the somatostatin analog SMS 201-955].
    Ligorria C; Montaña E; Virgili N
    Med Clin (Barc); 1989 Nov; 93(17):676. PubMed ID: 2559266
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone-refractory prostate carcinoma.
    Heidenreich A; Sommer F; Ohlmann CH; Schrader AJ; Olbert P; Goecke J; Engelmann UH
    Cancer; 2004 Sep; 101(5):948-56. PubMed ID: 15329902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.
    Chernicoff D; Bukowski RM; Groppe CW; Hewlett JS
    Cancer Treat Rep; 1979 May; 63(5):795-6. PubMed ID: 222449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.